Interactive Fitness Market 2020-2024- Featuring Axtion Technology LLC, EGYM Inc., among others to contribute to the market growth | Industry Analysis, Market Trends, Opportunities and Forecast 2024

LONDON–(BUSINESS WIRE)–The interactive fitness market is poised to grow by USD 4.81 bn during 2020-2024, progressing at a CAGR of almost 7% during the forecast period.

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the interactive fitness market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing awareness among people about fitness and a healthy lifestyle.

The interactive fitness market analysis includes end-user segment and geography landscape. This study identifies the adoption of fitness-related initiatives by corporates as one of the prime reasons driving the interactive fitness market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The interactive fitness market covers the following areas:

Interactive Fitness Market Sizing

Interactive Fitness Market Forecast

Interactive Fitness Market Analysis

Companies Mentioned

  • Axtion Technology LLC
  • Echelon Fitness Multimedia LLC
  • EGYM Inc.
  • Motion Fitness LLC
  • Nautilus Inc.
  • Nexersys Corp.
  • Paradigm Health and Wellness Inc.
  • Peloton Interactive Inc.
  • Tonal Systems Inc.

Related Reports on Consumer Discretionary Include:

  • Massage Equipment Market by Product, End-user, Type, and Geography – Forecast and Analysis 2020-2024– The massage equipment market size has the potential to grow by USD 3.27 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
  • Water Heater Market by End-user, Distribution Channel, Type, and Geography – Forecast and Analysis 2020-2024– The water heater market size has the potential to grow by USD 2.76 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes

Key Topics Covered:



  • 2.1 Preface
  • 2.2 Currency conversion rates for US$


  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis


  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024


  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition


  • Market segmentation by end-user
  • Comparison by end-user
  • Non-residential – Market size and forecast 2019-2024
  • Residential – Market size and forecast 2019-2024
  • Market opportunity by end-user



  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • APAC – Market size and forecast 2019-2024
  • South America – Market size and forecast
Read More

X-37, LLC Appoints David Gluckman, M.D., to Board of Directors

X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that David Gluckman, M.D., has joined the company’s Board of Directors. Dr. Gluckman is Vice Chairman of Investment Banking and Global Head of Lazard’s Healthcare Group. He has been with Lazard since 1998, providing strategic and financial advice to senior executives and boards of directors at leading healthcare companies globally.

“We welcome Dr. Gluckman to X-37’s Board of Directors and look forward to benefitting from his experience and expertise in corporate strategy and finance as we advance our discovery and development programs against a variety of pharmaceutical targets,” said David Collier, M.D., CEO and cofounder of X-37. “Dr. Gluckman’s network and experience will be very valuable to X-37 as we seek to capitalize on these developments through partnerships with, and acquisitions by, major pharmaceutical companies.”

X-37 identifies high-value drug targets, generates novel drug leads against these targets using Atomwise’s AI platform for structure-based drug design, and develops each of these drug programs to a medically-relevant inflection point, where it can be acquired by or partnered with a major pharmaceutical company to be brought to market. X-37 makes use of an LLC structure permitting each drug development program to be housed in a separate virtual company under the parent LLC. This structure allows X-37 to divest individual drug development programs, while maintaining the parent company and team.

“X-37’s flexible business model allows these successful drug hunters to do what they do best, discover and develop novel drug candidates for important diseases,” said Dr. Gluckman. “I look forward to providing strategic guidance to the X-37 leadership team to help them capitalize their multiple therapeutic opportunities.”

Dr. Gluckman is a member of the Advisory Board of the Vagelos Program in Life Sciences and Management, jointly administered by the College of Arts and Sciences and the Wharton School at the University of Pennsylvania. He is a member of the Board of Trustees of the Hackley School. He is a member of the Leadership Council of AmeriCares and is a Lazard representative in The Council of Foreign Relations, Corporate Leader Program. Prior to joining Lazard, Dr. Gluckman was a practicing physician in Toronto, Canada. Dr. Gluckman is a licentiate of the Medical Council of Canada and a member of the College of Physicians and Surgeons of Ontario.

About X-37

X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc., to screen vast libraries of chemical compounds against high value pharmaceutical targets. X-37 develops these novel drug candidates under an innovative LLC structure which allows the sale or partnership of individual development programs in a simple and efficient manner. The team at X-37 possesses deep expertise in pharmaceutical development and the selection of pharmaceutical targets of high importance. For more information, please visit

View source version on


Jessica Yingling, Ph.D., Little Dog Communications Inc., +1 858-344-8091, [email protected]

Source Article

Read More

Alcohol-free Guinness Beer Set to be Available Online in the USA with Beyond Spirits LLC by 2021


Guinness Beer Zero ABV will be available in the US next spring at Beyond Spirits LLC.
Guinness Beer Zero ABV will be available in the US next spring at Beyond Spirits LLC.
Guinness Beer Zero ABV will be available in the US next spring at Beyond Spirits LLC.

Fort Lauderdale, Florida, Oct. 23, 2020 (GLOBE NEWSWIRE) — Guinness Beer Zero ABV goes on sale in 4-440ml can pack in off-licences, and Waitrose and Morrisons supermarkets from Monday in the UK, before being rolled out to other retailers. But US consumers will have to wait until next spring to enjoy the new version of the popular Irish stout on draft available at Beyond Spirits LLC.

Even before lock-down, an increasing number of brewers offered more no- and low-alcohol alternatives. At the same time, Covid-related restrictions have increased consumers’ thirst for hangover-free options as drinking habits have become home-based.

Using a process that has taken four years to develop, brewers at its St James’s Gate site in Dublin begin by making Guinness to the traditional 261-year old recipe – with water, barley, hops, and yeast – before tweaking it to remove the alcohol through cold filtration.

The launch highlights our long-held commitment to innovation, experimentation, and bravery in brewing, harnessing the power of our brewers and hand-picked ingredients to create an alcohol-free beer that is 100% Guinness but 0% alcohol.”

Low-alcohol wines and spirits are also proving attractive to consumers. It is estimated there are about 70 no-alcohol spirits brands in the UK and the world, up from zero in 2011 when Arkay Beverages launched the world’s first alcohol-free collection of 24 alcohol-free spirits flavored drinks and its famous alcohol-free whisky.

About Beyond Spirits Market Place 

Beyond Spirits aims to become the world’s largest alcohol-free spirits marketplace where major alcohol-free spirits and beer brands will be available today; Beyond Spirits is Arkay Beverages’ official distributor for the US and Canada.

About ArKay Beverages Alcohol-Free Spirits 

Since 2011, Arkay Beverages has been fine-tuning various zero-proof spirit recipes, including vodka, tequila, gin, whisky, bourbon, and brandy, among many others, for the appreciation of fine liquor without the alcohol.

ArKay, the world’s first alcohol-free, liquor-flavored drink, is designed for everyone to enjoy. The exceptional taste of liquor without the alcohol content makes it a perfect beverage day or night. ArKay has 0% alcohol, and it is designed to allow individuals with medical conditions or religious beliefs that prohibit alcohol consumption and drink. Imagine being able to enjoy your favorite liquor drink at parties without worrying about drinking and driving. You won’t miss a thing, as ArKay tastes and looks exactly like traditional liquor. It is suitable for drinking straight-up, on the rocks, or with your favorite mixers.

Social Media 


Links : 


Reynald Grattagliano

T: 917 657 7126


This news has been published for the above source. Kiss PR Brand Story Press Release News Desk was not involved in the creation of this content. KISS PR and its distribution partners are not directly or

Read More